FindTrial
Sign In

Identification of components from Indian foods to look for their positive effects on liver disease patients.

Effects of Indian Foods and Ayurvedic drugs on healthy and diseased liver, under the Center of Excellence scheme. Project 1: Identification of Components from Indian Foods as Hepatoprotective Agents with Bile Secretion, Liver Regeneration and Effect on Gut Microbiome in Non-Alcoholic Fatty Liver Disease. - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079117
Enrollment
100
Registered
2025-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: Hepatoprotective Diet: The following hepatoprotective diet parameters will be evaluated separately with 20 patients each group: Ginger, carrot,buttermilk, Turmeric, and amla. Frequency

Sponsors

Ministry of AYUSH Government of India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Alcohol intake less than 20 gm 2. Hepatic Steatosis (CAP more than 250). 3. Metabolic Syndrome. 4. No other liver disease like hepatitis B,C, Wilson, hemochromatosis. 5. Metabolic Syndrome.

Exclusion criteria

Exclusion criteria: 1. Pregnant Females. 2. Cardiovascular disease and Chronic illness. 3. H/o estrogens,steroids,valproic acids,methotrexate,tetracyclin,and tamoxifen, weigh loss medicine.

Design outcomes

Primary

MeasureTime frame
Addition of individual food itesm in diet and its effects such as Ginger,Turmeric,Amla,Carrot,and buttermilk in NAFLD Indian patients.Timepoint: 3 months—

Secondary

MeasureTime frame
Investigate the effect of individual food components and gut microbiome alteration in NAFLD patients using Metagenomic approach in stool samples.Timepoint: 3 months—

Countries

India

Contacts

Public ContactDr S K Sarin

Institute of Liver and Biliary Sciences

shivsarin@gmail.com01146300000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026